Kalchem International

Warning letter

Headquarters

United States of America

Issue date

27 Aug 2020

Issuing office

Office of Pharmaceutical Quality Operations, Division II

Posted date

15 Sept 2020

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Products & Services

Drugs